Open-Label, Randomized, Single-Dose, 2-Way Crossover Bioequivalence Study Comparing A New Alprazolam Sublingual Tablet Formulation To A Reference Alprazolam Immediate Release Tablet.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 29 May 2012
At a glance
- Drugs Alprazolam; Alprazolam
- Indications Generalised anxiety disorder; Panic disorder
- Focus Pharmacokinetics
- Sponsors Pfizer
- 23 Feb 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 10 Feb 2011 Planned end date changed from 1 Mar 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 10 Feb 2011 Planned initiation date changed from 1 Jan 2011 to 1 Apr 2011 as reported by ClinicalTrials.gov.